Skip to main content
Clinical Trials/NCT00526123
NCT00526123CompletedNot Applicable

A Randomized, Open-label Comparison of the Performance and Longevity of a Split-tip Versus a Symmetric Tip Hemodialysis

Tyco Healthcare Group27 sites in 1 country599 target enrollmentStarted: September 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
599
Locations
27
Primary Endpoint
First Catheter Induced Complication

Study Overview

Brief Summary

The purpose of this clinical trial is to compare the longevity of two dialysis catheters.

Detailed Description

This study is a multi-center, randomized, prospective, open-label, clinical study comparing a conventional split-tip catheter and a symmetric tip catheter in subjects undergoing hemodialysis.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject must be 18 years of age or older.
  • Subject must meet labeled indication for hemodialysis.
  • Subject must have End Stage Renal Disease (ESRD).
  • Subject must have a patent right or left internal jugular vein.
  • Subject treatment plan must require chronic hemodialysis treatments 3 times per week for a minimum of 6 weeks.
  • Subject must give written informed consent.

Exclusion Criteria

  • Subjects who are concurrently enrolled in any Randomized Clinical Trial (RCT) or those that may enroll in a RCT during the course of the study, or subjects who have been previously randomized into this clinical study.
  • Subjects with active infection at the time of study enrollment.
  • Subjects with a known sensitivity to heparin, or previous incidence of heparin-induced thrombocytopenia.
  • Subjects with uncontrolled abnormal coagulation parameters and are at additional risk for clotting or excessive bleeding.
  • Subjects who are known or suspected to be pregnant at the time of study enrollment or plan to get pregnant during the study period.
  • Subjects for whom performing dialysis at flow rates up to 450 mL/min would be contraindicated for any reason.
  • Subject unable or unwilling to commit to follow-up visits and study procedures throughout the course of the study.
  • Subjects who, in the opinion of the Investigators, are not appropriate candidates for the study based upon current or past medical history, or negative past experience with either of the study catheters.

Outcomes

Primary Outcomes

First Catheter Induced Complication

Time Frame: 245 days

% of participants that did not experience a catheter induced complication at the specified Outcome Measure Time Frame.

Secondary Outcomes

  • Inadequate Flow Rates Requiring Surgical/Radiological Intervention(35 weeks)
  • Average Number of Line Reversals Per Subject(35 Weeks)
  • Frequency of Clinician Interventions for Catheter Malfunction and Infection(35 Weeks)
  • Primary Failure Rate(First dialysis session with study catheter)
  • Reliability of the Catheter(35 Weeks)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (27)

Loading locations...

Similar Trials